Martin & Pleasance Pty Ltd v A Nelson & Co Ltd

Link copied
Case Copied 35 min read

FEDERAL COURT OF AUSTRALIA

Martin & Pleasance Pty Ltd v A Nelson & Co Ltd [2021] FCAFC 80

Appeal from: A Nelson & Co Limited v Martin & Pleasance Pty Ltd (No 2) [2021] FCA 228
File number: NSD 237 of 2021
Judgment of: JAGOT, YATES AND JACKSON JJ
Date of judgment: 4 May 2021
Date of publication of reasons:

27 May 2021

Catchwords: PRACTICE AND PROCEDURE – application for leave to appeal from an interlocutory judgment of a single judge of the Court – where primary judge granted an interlocutory injunction in proceedings alleging trade mark infringement, passing off and contravention of ss 18 and 29 of the Australian Consumer Law (Sch 2 to the Competition and Consumer Act 2010 (Cth)) – leave to appeal granted and appeal dismissed
Legislation:

Competition and Consumer Act 2010 (Cth), Schedule 2 (Australian Consumer Law) s 18

Trade Marks Act 1995 (Cth) s 122

Therapeutic Goods Regulations 1990 (Cth)

Therapeutic Goods Advertising Code (No 2) 2018 (Cth) s 23

Cases cited:

Boyd v Wild Hibiscus Flower Company Pty Ltd (No 2) [2012] FCA 74

Campbell v Sutherland [2020] FCA 765

Garden Cottage Foods Ltd v Milk Marketing Board [1984] AC 130

House v The King (1936) 55 CLR 499

Samsung Electronics Co. Limited v Apple Inc. [2011] FCAFC 156; (2011) 217 FCR 238

S&I Publishing Pty Ltd v Australian Surf Life Saver Pty Ltd [1998] FCA 1463; (1998) 88 FCR 354

Silktone Pty Ltd v Devreal Capital Pty Ltd (1990) 21 NSWLR 317

Sportsbet Pty Ltd v Crownbet Pty Ltd [2018] FCA 1045

Division: General Division
Registry: New South Wales
National Practice Area: Intellectual Property
Sub-area: Trade Marks
Number of paragraphs: 84
Date of hearing: 4 May 2021
Counsel for the Appellants: Mr MJ Darke SC with Mr DB Larish
Solicitor for the Appellants: Corrs Chambers Westgarth
Counsel for the Respondents: Mr N Murray SC with Ms A Campbell
Solicitor for the Respondents: Gilbert + Tobin

ORDERS

NSD 237 of 2021
BETWEEN:

MARTIN & PLEASANCE PTY LTD (ACN 006 935 888)

First Appellant

ALOE VERA INDUSTRIES PTY LTD (ACN 063 710 832)

Second Appellant

MARTIN & PLEASANCE WHOLESALE PTY LTD

Third Appellant

AND:

A NELSON & CO LTD

First Respondent

BACH FLOWER REMEDIES LTD

Second Respondent

ORDER MADE BY:

JAGOT, YATES AND JACKSON JJ

DATE OF ORDER:

4 MAY 2021

THE COURT ORDERS THAT:

1.Leave to appeal be granted.

2.The appeal be dismissed.

3.The appellants pay the respondents’ costs of and in connection with the leave application and the appeal as agreed or taxed.

Note:   Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.


REASONS FOR JUDGMENT

THE COURT:

  1. These reasons concern an application for leave to appeal and consequential appeal concerning alleged passing off, misleading or deceptive conduct and trade mark infringement.  The appellants (and applicants) are Martin & Pleasance Pty Ltd and related companies, and the respondents are A Nelson & Co Ltd and related companies.

  2. On 17 March 2021, the primary…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Martin & Pleasance Pty Ltd v A Nelson & Co Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2021] FCAFC 80
Decision Date

CaseChat Overview and Summary

Martin & Pleasance Pty Ltd v A Nelson & Co Ltd involves a dispute between two groups of companies, with the respondents based in the United Kingdom and the appellants in Australia. The respondents, who have manufactured a “Rescue” range of complementary medicines for over 30 years, commenced proceedings against the appellants, who had been their Australian distributors. After the respondents terminated their distribution agreement, the appellants launched their own range of products, named “RestQ”, which were similar to the respondents’ products. The respondents sought interlocutory relief on the basis of trade mark infringement, passing off, and breaches of the Australian Consumer Law. The primary judge granted an interlocutory injunction, restraining the appellants from marketing and supplying their “RestQ” products, which led to the appellants seeking leave to appeal and subsequently appealing the primary judge’s decision.

The court was required to decide whether the appellants were granted leave to appeal the interlocutory judgment of the primary judge. The appeal was focused on the interlocutory injunction that restrained the appellants from marketing, promoting, and supplying their “RestQ” range of complementary medicines. The legal issues included whether the respondents had established a prima facie case of passing off and misleading or deceptive conduct, and whether the balance of convenience favoured the respondents.

The court granted leave to appeal and dismissed the appeal. The court found that the respondents had made out a prima facie case of passing off and misleading or deceptive conduct, but did not base its decision on trade mark infringement because the appellants had raised a defence under s 122(1)(b) of the Trade Marks Act 1995 (Cth). The court concluded that the balance of convenience favoured the respondents because they had been in the homeopathic market for a longer period and had established a reputation and goodwill in that market. The court also noted that the substantive order made by the primary judge was relatively short, and the stay of the order was subsequently extended.

The final orders of the court were that leave to appeal was granted, the appeal was dismissed, and the appellants were to pay the respondents’ costs of and in connection with the leave application and the appeal as agreed or taxed.

Orders

Orders of the court

1. Leave to appeal be granted.

2. The appeal be dismissed.

3. The appellants pay the respondents’ costs of and in connection with the leave application and the appeal as agreed or taxed.

Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.

Background

Background to the litigation

On 17 March 2021, the primary judge granted an injunction which restrained the appellants from marketing, promoting and/or supplying their “RestQ” range of complementary medicines. On 4 May 2021, we heard the application for leave to appeal and full argument on the appeal. At the end of the hearing we made orders granting leave to appeal and dismissing the appeal. These are our reasons for those orders.Background The respondents are a group of companies based in the United Kingdom. For many years they have manufactured a “Rescue” range of complementary medicines (the “Rescue” products). For over 30 years, the appellants acted as the distributor of those products in Australia. The “Rescue” products were sold to consumers through a range of retail channels including pharmacists and supermarkets. The products were marketed as “flower remedies” which had been devised in the 1920s and 1930s by a medical doctor called Edward Bach who had particular research interests in homeopathy. They were: oral drops for the relief of stress called “Rescue Remedy”; oral drops and an oral spray for the relief of sleeplessness called “Rescue Sleep” and “Rescue Sleep Spray”; several varieties of “Rescue Pastilles” for stress relief; and “Rescue Plus” lozenges for “clarity and composure”. It was common ground that the respondents had built up a substantial goodwill and reputation in Australia in relation to the products. One respondent company is the owner of Australian registered trade marks “Rescue” and “Rescue Sleep” in the relevant category of goods. In October 2020, the respondents gave notice to the appellants that the distribution agreement for the “Rescue” products would be terminated. The appellants planned to launch their own range of products made using methods associated with Dr Bach. Those products were launched to the market on 15 February 2021. They were: oral drops and an oral spray for sleeplessness marketed as “RestQ Sleep Formula”; oral drops, an oral spray and pastilles marketed as “RestQ Calm Formula”; and an oral spray known as “RestQ Focus Formula” (the “RestQ” products). It is convenient to illustrate the similarities and differences in the respective get ups by reproducing side by side pictures of the products with the closest correspondence, namely the sleep products. The respondents commenced proceedings against the appellants on 2 March 2021. The statement of claim alleged infringement of the registered trade marks, passing off, and conduct in breach of ss 18 and 29 of the Australian Consumer Law (ACL). The originating application sought interlocutory relief restraining the appellants from offering, marketing, promoting and/or supplying products or participating in any of those activities using the words “RestQ” or “Bach” or using the packaging depicted in the statement of claim (from which the above picture of the appellants’ sleep products is taken). The interlocutory relief also sought orders requiring the deactivation of a website, and Facebook and Instagram accounts, used to market the “RestQ” products.The primary judgment

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

The respondents commenced proceedings against the appellants on 2 March 2021. The statement of claim alleged infringement of the registered trade marks, passing off, and conduct in breach of ss 18 and 29 of the Australian Consumer Law (ACL). The originating application sought interlocutory relief restraining the appellants from offering, marketing, promoting and/or supplying products or participating in any of those activities using the words “RestQ” or “Bach” or using the packaging depicted in the statement of claim (from which the above picture of the appellants’ sleep products is taken). The interlocutory relief also sought orders requiring the deactivation of a website, and Facebook and Instagram accounts, used to market the “RestQ” products.The primary judgment The primary judge heard the application for interlocutory relief on 10 March 2021 and, as has been indicated, substantially granted it one week later. His Honour found that the respondents had made out a prima facie case of passing off and misleading or deceptive conduct. He declined to base his decision on trade mark infringement because the appellants had raised a defence to that under s 122(1)(b) of the Trade Marks Act 1995 (Cth), known as the good faith defence, and determining the strength or weakness of that defence might lead to an inquiry into the good faith or lack thereof of the appellants’ Managing Director, Richard Holyman. Since the application could be disposed of on other grounds, it was not necessary to consider that issue at the interlocutory stage. On the question of balance of convenience, the primary judge summarised his conclusion at [55] as follows:At a very superficial level, but at an important level, the facts fell in favour of the Applicant [the present respondents] by reason of the fact that:• it had been in the homeopathic market for some time, having held (for example) exclusive rights to the supply of the ingredients the subject of the ‘RESCUE’ products since late 1993; and• it had established a reputation and goodwill in that market.By way of contrast, the Respondents [appellants]:• had only entered the market in mid-February 2021; and• had a less well-established market presence, albeit a presence which was growing at some pace. The substantive order the primary judge made was that:(a)[the appellants] be restrained from marketing, promoting and/or supplying products (or offering to supply products) or participating in any such marketing, promotion or supply:(i)using the word ‘RestQ’; and/or(ii)using the packaging the subject of the photograph comprising annexure B to the Statement of Claim filed on 2 March 2021 (‘RestQ Packaging’); and(b)the First and/or Third Respondent [appellants] to deactivate the Facebook account with the handle RestQMP, the Instagram account with the handle RestQ_MP and remove the website within 24 hours of the making of this order. The primary judge granted a relatively short stay of his orders, which was subsequently extended by a different judge to expire on the afternoon of the hearing of the application for leave to appeal.Leave to appeal

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.